A Comparative Study of the Anti-Platelet Effects of cis- and trans-Resveratrol

  • Kim, Hwa (College of Pharmacy, Chonnam National University) ;
  • Oh, Seok-Jeong (College of Pharmacy, Chonnam National University) ;
  • Liu, Yingqiu (College of Pharmacy, Chonnam National University) ;
  • Lee, Moo-Yeol (College of Pharmacy, Chonnam National University)
  • Received : 2011.01.22
  • Accepted : 2011.02.07
  • Published : 2011.04.30


Although various biological activities of resveratrol have been extensively studied, most reports have focused on trans-resveratrol and little attention has been paid to the cis-isomer. In this study, the effect of cis-resveratrol on platelet activity was examined and compared with that of the trans-isomer. Treatment with cis-resveratrol resulted in inhibition of platelet aggregation induced by thrombin, collagen or ADP, which are representative aggregation-inducing agents, and the trans-isomer elicited the same effects. These effects were concentration-dependent in the range of 1-100 ${\mu}M$. However, the potency of the cis-isomer was much lower than that of the trans-isomer; the $IC_{50}$ values for the cis-isomer versus the trans-isomer were $31{\pm}12$ vs $151{\pm}3$, $161{\pm}3$ vs $91{\pm}4$, and $601{\pm}15$ vs $251{\pm}6\;{\mu}M$ for thrombin-, collagen- and ADP-induced aggregation, respectively. These results indicate that cis-resveratrol has a less potent anti-platelet activity, compared with the trans-isomer, and raise the possibility that the biological activities of the cis-isomer may be different from those of the trans-isomer. It will be necessary to evaluate the activity of cis-resveratrol independently of the trans-isomer.


  1. Aumont, V., Krisa, S., Battaglia, E., Netter, P., Richard, T., Merillon, J. M., Magdalou, J. and Sabolovic, N. (2001) Regioselective and stereospecific glucuronidation of trans- and cis-resveratrol in human. Arch. Biochem. Biophys. 393, 281-289.
  2. Bertelli, A. A., Giovannini, L., Bernini, W., Migliori, M., Fregoni, M., Bavaresco, L. and Bertelli, A. (1996). Antiplatelet activity of cis-resveratrol. Drugs Exp. Clin. Res. 22, 61-63.
  3. Campos-Toimil, M., Elies, J., Alvarez, E., Verde, I. and Orallo, F. (2007). Effects of trans- and cis-resveratrol on $Ca^{2+}$ handling in A7r5 vascular myocytes. Eur. J. Pharmacol. 577, 91-99.
  4. Campos-Toimil, M., Elies, J. and Orallo, F. (2005) Trans- and cisresveratrol increase cytoplasmic calcium levels in A7r5 vascular smooth muscle cells. Mol. Nutr. Food Res. 49, 396-404.
  5. Crescente, M., Jessen, G., Momi, S., Holtje, H. D., Gresele, P., Cerletti, C. and de Gaetano, G. (2009) Interactions of gallic acid, resveratrol, quercetin and aspirin at the platelet cyclooxygenase-1 level Functional and modelling studies. Thromb. Haemostasis. 102, 336-346.
  6. Cvejic, J. M., Djekic, S. V., Petrovic, A. V., Atanackovic, M. T., Jovic, S. M., Brceski, I. D. and Gojkovic-Bukarica, L. C. (2010) Determination of trans- and cis-resveratrol in Serbian commercial wines. J. Chromatogr. Sci. 48, 229-234.
  7. Dobrydneva, Y., Williams, R. L. and Blackmore, P. F. (1999) trans-Resveratrol inhibits calcium influx in thrombin-stimulated human platelets. Brit. J. Pharmacol. 128, 149-157.
  8. Fremont, L. (2000) Biological effects of resveratrol. Life Sci. 66, 663-673.
  9. Gresele, P., Pignatelli, P., Guglielmini, G., Carnevale, R., Mezzasoma, A. M., Ghiselli, A., Momi, S. and Violi, F. (2008) Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J. Nutr. 138, 1602-1608.
  10. Lee, M. Y., Bae, O. N., Chung, S. M., Kang, K. T., Lee, J. Y. and Chung, J. H. (2002) Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease. Toxicol. Appl. Pharmacol. 179, 83-88.
  11. Leiro, J., Alvarez, E., Arranz, J. A., Laguna, R., Uriarte, E. and Orallo, F. (2004) Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes. J. Leukoc. Biol. 75, 1156-1165.
  12. Olas, B. and Wachowicz, B. (2005) Resveratrol, a phenolic antioxidant with effects on blood platelet functions. Platelets 16, 251-260.
  13. Olas, B., Wachowicz, B., Holmsen, H. and Fukami, M. H. (2005) Resveratrol inhibits polyphosphoinositide metabolism in activated platelets. BBA-Biomembranes 1714, 125-133.
  14. Olas, B., Wachowicz, B., Saluk-Juszczak, J., Zielinski, T., Kaca, W. and Buczynski, A. (2001a) Antioxidant activity of resveratrol in endotoxin-stimulated blood platelets. Cell Biol. Toxicol. 17, 117-125.
  15. Olas, B., Wachowicz, B., Szewczuk, J., Saluk-Juszczak, J. and Kaca, W. (2001b) The effect of resveratrol on the platelet secretory process induced by endotoxin and thrombin. Microbios 105, 7-13.
  16. Olas, B., Zbikowska, H. M., Wachowicz, B., Krajewski, T., Buczynski, A. and Magnuszewska, A. (1999) Inhibitory effect of resveratrol on free radical generation in blood platelets. Acta. Biochim. Pol. 46, 961-966.
  17. Orallo, F. (2006) Comparative studies of the antioxidant effects of cisand trans-resveratrol. Curr. Med. Chem. 13, 87-98.
  18. Pettit, G. R., Grealish, M. P., Jung, M. K., Hamel, E., Pettit, R. K., Chapuis, J. C. and Schmidt, J. M. (2002) Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate. J. Med. Chem. 45, 2534-2542.
  19. Rius, C., Abu-Taha, M., Hermenegildo, C., Piqueras, L., Cerda-Nicolas, J. M., Issekutz, A. C., Estan, L., Cortijo, J., Morcillo, E. J., Orallo, F. and Sanz, M. J. (2010) Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-kappaB activation and peroxisome proliferator-activated receptor-gamma upregulation. J. Immunol. 185, 3718-3727.
  20. Shen, M. Y., Hsiao, G., Liu, C. L., Fong, T. H., Lin, K. H., Chou, D. S. and Sheu, J. R. (2007) Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP. Brit. J. Haematol. 139, 475-485.
  21. Soleas, G. J., Diamandis, E. P. and Goldberg, D. M. (1997) Resveratrol: a molecule whose time has come? And gone? Clin. Biochem. 30, 91-113.
  22. Stivala, L. A., Savio, M., Carafoli, F., Perucca, P., Bianchi, L., Maga, G., Forti, L., Pagnoni, U. M., Albini, A., Prosperi, E. and Vannini, V. (2001) Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J. Biol. Chem. 276, 22586-22594.
  23. Vitrac, X., Bornet, A., Vanderlinde, R., Valls, J., Richard, T., Delaunay, J. C., Merillon, J. M. and Teissedre, P. L. (2005) Determination of stilbenes (delta-viniferin, trans-astringin, trans-piceid, cis- and trans-resveratrol, epsilon-viniferin) in Brazilian wines. J. Agric. Food Chem. 53, 5664-5669.
  24. Yang, Y. M., Chen, J. Z., Wang, X. X., Wang, S. J., Hu, H. and Wang, H. Q. (2008a) Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity. Eur. J. Pharmacol. 583, 148-155.
  25. Yang, Y. M., Wang, X. X., Chen, J. Z., Wang, S. J., Hu, H. and Wang, H. Q. (2008b) Resveratrol attenuates adenosine diphosphate-induced platelet activation by reducing protein kinase C activity. Am. J. Chinese Med. 36, 603-613.
  26. Zamora-Ros, R., Andres-Lacueva, C., Lamuela-Raventos, R. M., Berenguer, T., Jakszyn, P., Martinez, C., Sanchez, M. J., Navarro, C., Chirlaque, M. D., Tormo, M. J., Quiros, J. R., Amiano, P., Dorronsoro, M., Larranaga, N., Barricarte, A., Ardanaz, E. and Gonzalez, C. A. (2008) Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort. Br. J. Nutr. 100, 188-196.
  27. Zbikowska, H. M. and Olas, B. (2000) Antioxidants with carcinostatic activity (resveratrol, vitamin E and selenium) in modulation of blood platelet adhesion. J. Physiol. Pharmacol. 51, 513-520.
  28. Zbikowska, H. M., Olas, B., Wachowicz, B. and Krajewski, T. (1999) Response of blood platelets to resveratrol. Platelets 10, 247-252.

Cited by

  1. Bioactive Components and Health-Promoting Properties of Yuzu (Citrus ichangensis × C. reticulate) vol.30, pp.2, 2014,
  2. Anti-platelet and anti-thrombotic effect of a traditional herbal medicine Kyung-Ok-Ko vol.178, 2016,
  3. Anti-platelet effects of yuzu extract and its component vol.49, pp.12, 2011,
  4. Inhibitory Effect of Allyl Isothiocyanate on Platelet Aggregation vol.62, pp.29, 2014,
  5. Inhibitory Effects of Yuzu and Its Components on Human Platelet Aggregation vol.23, pp.2, 2015,
  6. Ultraviolet Irradiation of Trans-Resveratrol and HPLC Determination of Trans-Resveratrol and Cis-Resveratrol in Romanian Red Wines vol.50, pp.10, 2012,
  7. Acetic acid in aged vinegar affects molecular targets for thrombus disease management vol.6, pp.8, 2015,
  8. Alditols and monosaccharides from sorghum vinegar can attenuate platelet aggregation by inhibiting cyclooxygenase-1 and thromboxane-A2 synthase vol.155, pp.1, 2014,